TrialAJNR. American journal of neuroradiology2022

Radiomics-Based Machine Learning for Outcome Prediction in a Multicenter Phase II Study of Programmed Death-Ligand 1 Inhibition Immunotherapy for Glioblastoma.

E George et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.